EVQLV

📍 New York, United States🗓 Founded 2019👥 10 employees💰 Last funded Apr 2022
Biotechnology🌐 evqlv.com
Website LinkedIn
EVQLV leverages advances in computation to revolutionize the design and development of therapeutic antibodies. We work with partners at the discovery stage to accelerate the speed of antibody discovery. For those collaborators who have preclinical, clinical, or commercial assets, we support the optimization of antibody candidates, develop assets that expand IP protection, and design next generation and innovative immunotherapies. All of our work is performed at accelerated speeds and scale only feasible by leveraging computational tools that learn from massive and diverse datasets.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in EVQLV?
EVQLV has 1 investors on record on gritt.io, 1 mid-stage.
When did EVQLV last raise funding?
The most recent investment in EVQLV recorded on gritt.io was in April 2022.
When was EVQLV founded?
EVQLV was founded in 2019.
What industry is EVQLV in?
EVQLV operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is EVQLV based?
EVQLV is headquartered in New York, United States.